Rehabilitation in Women with Breast Cancer

Physical Medicine and Rehabilitation Clinics of North America

Volumn 18, Issue 3, 2007, Pages 521-537

  Silver, Julie K ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER PAIN; CANCER PREVENTION; CANCER RECURRENCE; CANCER REHABILITATION; CANCER THERAPY; EXERCISE; FATIGUE; FEMALE; HUMAN; PATIENT CARE; PHYSICAL MEDICINE; PRIORITY JOURNAL; REHABILITATION CARE; REHABILITATION MEDICINE; REVIEW;

BREAST NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; QUALITY OF LIFE; REHABILITATION;

EID: 34547167917     PISSN: 10479651     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pmr.2007.05.003     Document Type: Review

References (93)

1. In: Silva O.E., and Zurrida S. (Eds). Breast cancer: a practical guide. 3rd edition (2005), Elsevier Saunders, New York p. 15, 21-3, 24
2. Olson J.S. Bathsheba's breast (2002), Johns Hopkins University Press, Baltimore (MD) p. 13, 68-9
3. Sheed W. In love with daylight: a memoir of recovery (1999), Akadine Press, Pleasantville p. 234
4. French M. A season in hell (2000), Ballantine, New York p. 60
5. Ross W. Crusade: the official history of the American Cancer Society® (1987), Arbor House, New York p. 18
6. Jemal A., Murray T., Ward E., et al. Cancer statistics, 2005. CA Cancer J Clin 55 (2005) 10-30
7. Kligman L., Wong R.K.S., Johnston M., et al. The treatment of lymphedema related to breast cancer: a systematic review and evidence summary. Support Cancer Care 12 (2004) 421-431
8. Karki A., Simonen R., Malkia E., et al. Impairments, activity limitations and participation restrictions 6 and 12 months after breast cancer operation. J Rehabil Med 37 (2005) 180-188
9. Rietman J.S., Dijkstra P.U., Debreczeni R., et al. Impairments, disabilities and health related quality of life after treatment for breast cancer: a follow-up study 2.7 years after surgery. Disabil Rehabil 26 (2004) 78-84
10. Fehlauer F., Tribius S., Mehnert A., et al. Health-related quality of life in long term cancer survivors treated with breast conserving therapy: impact of age at therapy. Breast Cancer Res Treat 92 (2005) 217-222
11. Sweeny C., Schmitz K.H., Lazovich D., et al. Functional limitations in elderly female cancer survivors. J Natl Cancer Inst 98 (2006) 521-529
12. Gordon L.G., Battistutta D., Scuffham P., et al. The impact of rehabilitation support services on health-related quality of life for women with breast cancer. Breast Cancer Res Treat 93 (2005) 217-226
13. Chilson T., Chan F., Lonser F., et al. Seroma prevention after modified radical mastectomy. Am Surg 58 (1992) 750-754
14. Gonzalez E.A., Saltzstein E.C., Riedner C.S., et al. Seroma formation following breast cancer surgery. Breast J 9 (2003) 385-388
15. Haid A., Koberle-Wuhrer R., Knauer M., et al. Morbidity of breast cancer patients following complete axillary dissection or sentinel node biopsy only: a comparative evaluation. Breast Cancer Res Treat 73 (2002) 31-36
16. Rietman J.S., Dijkstra P.U., Geertzent J.H.B., et al. Treatment-related upper limb morbidity 1 year after sentinel lymph node biopsy or axillary lymph node dissection for stage I or II breast cancer. Ann Surg Oncol 11 (2004) 1018-1024
17. Rietman J.S., Geertzen J.H.B., Hoekstra H.J., et al. Long term treatment related upper limb morbidity and quality of life after sentinel lymph node biopsy for stage I and II breast cancer. Eur J Surg Oncol 32 (2006) 148-152
18. Ronka R., von Smitten K., Tasmuth T., et al. One-year morbidity after sentinel node biopsy and breast surgery. Breast 14 (2005) 28-36
19. Schulze T., Mucke J., Markwardt J., et al. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection. J Surg Oncol 93 (2006) 109-119
20. Canavese G., Catturich A., Vecchio C., et al. Prognostic role of lymph-node level involvement in patients undergoing axillary dissection for breast cancer. Eur J Surg Oncol 24 (1998) 104-109
21. Jatoi I., Hilsenbeck S.G., Clark G.M., et al. Significance of axillary lymph node metastasis in primary breast cancer. J Clin Oncol 17 (1999) 2334-2340
22. Crompvoets S. Comfort, control, or conformity: women who choose breast reconstruction following mastectomy. Health Care Women Int 27 (2006) 75-93
23. Losken A., Carlson G.W., Schoemann M.B., et al. Factors that influence the completion of breast reconstruction. Ann Plast Surg 52 (2004) 258-262
24. Futter C.M., Webster M.H.C., Hagen S., et al. A retrospective comparison of abdominal muscle strength following breast reconstruction with a free TRAM and DIEP flap. Br J Plast Surg 53 (2000) 578-583
25. Alderman AK, Kuzon WM, Wilkins EG. A two-year prospective analysis of trunk function in TRAM breast reconstructions. Plast Reconstr Surg 20006;117:2131-8.
26. Gianni L., and Capri G. New chemotherapy drugs. In: Bonadonna G., Hortobagyi G.N., and Gianni A.M. (Eds). Textbook of breast cancer-a clinical guide to therapy (1997), Martin Dunitz Ltd, London 253-280
27. Makino H. Treatment and care of neurotoxicity from taxane anticancer agents. Breast Cancer 11 (2004) 100-104
28. Orzano J.A., and Swain S.A. Concepts and clinical trials of dose-dense chemotherapy for breast cancer. Clin Breast Cancer 6 (2005) 402-411
29. Deutsch M., and Flickinger J.C. Shoulder and arm problems after radiotherapy for primary breast cancer. Am J Clin Oncol 24 (2001) 172-176
30. Meric F., Bucholz T.A., Mirza N.Q., et al. Long-term complications associated with breast-conservation surgery and radiotherapy. Ann Surg Oncol 9 (2002) 543-549
31. Beenken S.W., and Bland K.I. Long-term complications of breast-conservation therapy: can the incidence be reduced?. Ann Surg Oncol 9 (2002) 524-525
32. Blomqvist L., Stark B., Engler N., et al. Evaluation of arm and shoulder mobility and strength after modified radical mastectomy and radiotherapy. Acta Oncol 43 (2004) 280-283
33. Gaya A.M., and Ashford R.F.U. Cardiac complications of radiation therapy. Clin Oncol 17 (2005) 153-159
34. Pierce L.J. The use of radiotherapy after mastectomy: a review of the literature. J Clin Oncol 23 (2005) 1706-1717
35. Senkus-Konefka E., and Jassem J. Complications of breast-cancer radiotherapy. Clin Oncol 18 (2006) 229-235
36. Ranger G.S. Current concepts in the endocrine therapy of breast cancer: tamoxifen and aromatase inhibitors. J Clin Pharm Ther 30 (2005) 313-317
37. In: Hewitt M., Greenfield S., and Stovall E. (Eds). From cancer patient to cancer survivor: lost in transition (2006), The National Academies Press, Washington, DC
38. Holmes M.D., Chen W.Y., Feskanich D., et al. Physical activity and survival after breast cancer. JAMA 293 (2005) 2479-2486
39. McNeely M.L., Campbell K.L., Rowe B.H., et al. Effects of exercise on breast cancer patients and survivors: a systematic review and meta-analysis. CMAJ 175 (2006) 34-41
40. Dallal C.M., Sullivan-Halley J., Ross R.K., et al. Long-term recreational physical activity and risk of invasive and in situ breast cancer. Arch Intern Med 167 (2007) 408-415
41. MacVicar M.G., Winningham M.L., and Nickel J.L. Effects of aerobic interval training on cancer patients' functional capacity. Nurs Res 38 (1989) 348-351
42. MacVicar M.G., and Winningham M.L. Promoting functional capacity of cancer patients. Cancer Bull 38 (1986) 235-239
43. Mock V., Dow K.H., Meares C.J., et al. Effects of exercise on fatigue, physical functioning, and emotional distress during radiation therapy for breast cancer. Oncol Nurs Forum 24 (1997) 991-1000
44. Mock V., Pickett M., Ropka M.E., et al. Fatigue and quality of life outcomes of exercise during cancer treatment. Cancer Pract 9 (2001) 119-127
45. Schwartz A.L., Mori M., Gao R., et al. Exercise reduces daily fatigue in women with breast cancer receiving chemotherapy. Med Sci Sports Exerc 33 (2001) 718-723
46. Segal R., Evans W., Johnson D., et al. Structured exercise improves physical functioning in women with Stage I and II breast cancer: results of a randomized controlled trial. J Clin Oncol 19 (2001) 657-665
47. Couneya K.S., Mackey J.R., Bell G.J., et al. Randomized controlled trial of exercise in postmenopausal breast cancer survivors: cardiopulmonary and quality of life outcomes. J Clin Oncol 21 (2003) 1660-1668
48. Pinto B.M., and Trunzo J.J. Body esteem and mood among sedentary and active breast cancer survivors. Mayo Clin Proc 79 (2004) 181-186
49. Hoff A.O., and Gagel R.F. Osteoporosis in breast and prostate cancer survivors. Oncol 19 (2005) 651-658
50. Oldervoll L.M., Loge J.H., Paltiel H., et al. The effect of a physical exercise program in palliative care: a Phase II study. J Pain Symptom Manage 31 (2006) 421-430
51. Courneya K.S., and Friedenreich C.M. Relationship between exercise pattern across the cancer experience and quality of life in colorectal cancer survivors. J Altern Complement Med 3 (1997) 215-226
52. Denmark-Wahnefried W., Hars V., Conaway M.R., et al. Reduced rates of metabolism and decreased physical activity in breast cancer patients receiving adjuvant therapy. Am J Clin Nutr 65 (1997) 1495-1501
53. Midtgaard J., Tveteras A., Rorth M., et al. The impact of supervised exercise intervention on short-term postprogram leisure time physical activity level in cancer patients undergoing chemotherapy: 1- and 3-month follow-up on the body & cancer project. Palliat Support Care 4 (2006) 25-35
54. Herrero F., San Juan A.F., Fleck S.J., et al. Combined aerobic and resistance training in breast cancer survivors: a randomized, controlled pilot trial. Int J Sports Med 27 (2006) 573-580
55. Shamley D.R., Barker K., Simonite V., et al. Delayed versus immediate exercises following surgery for breast cancer: a systematic review. Breast Cancer Res Treat 90 (2005) 263-271
56. Ahmed R.L., Thomas W., Yee D., et al. Randomized controlled trial of weight training and lymphedema in breast cancer survivors. J Clin Oncol 24 (2006) 2765-2772
57. Hase K., Kamisako M., Fujiwara T., et al. The effect of zaltoprofen on physiotherapy for limited shoulder movement in breast cancer patients: a single-blinded before-after trial. Arch Phys Med Rehabil 87 (2006) 1618-1622
58. Lauridesen M.C., Christiansen P., and Hessov I.B. The effects of physiotherapy on shoulder function in patients surgically treated for breast cancer: a randomized study. Acta Oncol 44 (2005) 449-457
59. Ferreira de Rezende L., Franco R.L., Ferreira de Rezende M., et al. Two exercise schemes in postoperative breast cancer: comparison of effects on shoulder movement and lymphatic disturbance. Tumori 92 (2006) 55-61
60. Silver J, Mayer RS. Barriers to pain management in the rehabilitation of the surgical oncology patient. J Surg Oncol 2007;95:427-35.
61. Cella D.F., Tulsky D.S., Gray G., et al. The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 11 3 (1993) 570-579
62. Coscarelli Schag C.A., and Heinrich R.L. Development of a comprehensive quality of life measurement tool: CARES. Oncology 4 5 (1990) 135-138
63. Coscarelli Schag C.A., Ganz P.A., and Heinrich R.L. Cancer rehabilitation evaluation system-short form (CARES-SF). Cancer 68 (1991) 1406-1413
64. Spitzer W.O., Dobson A.J., Hall J., et al. Measuring the quality of life of cancer patients: a concise QL index for use by physicians. J Chronic Dis 34 (1981) 585-597
65. Watt-Watson J.H., and Graydon J.E. Sickness impact profile: a measure of dysfunction with chronic pain patients. J Pain Symptom Manage 4 (1989) 152-156
66. Bardsley M.J., Astell S., McCallum A., et al. The performance of three measures of health status in an outpatient diabetes population. Diabet Med 10 (1993) 619-626
67. Hays R.D., Sherbourne C.D., and Mazel R.M. The RAND 36-item health survey 1.0. Health Econ 2 3 (1993) 217-227
68. Aaronson N.K., Bullinger M., and Ahmedzai S. A modular approach to quality of life assessment in cancer clinical trials. Recent Results Cancer Res 111 (1988) 231-249
69. Aaronson N.K., Ahmedzai S., Bergman B., et al. The European organisation for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85 5 (1993) 365-376
70. Watson M., Law M., Maguire G.P., et al. Further development of a quality of life measure for cancer patients: the Rotterdam symptom checklist (revised). Psychooncology 1 (1992) 35-44
71. Westrup J.L., Lash T.L., Thwin S.S., et al. Risk of decline in upper-body function and symptoms among older breast cancer patients. J Gen Intern Med 21 (2006) 327-333
72. Carpenter J.S., Sloan P., Andrykowski M.A., et al. Risk factors for pain after mastectomy/lumpectomy. Cancer Pract 7 (1999) 66-70
73. Stevens P.E., Dibble S.L., and Miaskowski C. Prevalence, characteristics, and impact of postmastectomy pain syndrome: an investigation of women's experiences. Pain 61 (1995) 61-68
74. Carpenter J.S., Andrykowski M.A., Sloan P., et al. Postmastectomy/postlumpectomy pain in breast cancer survivors. J Clin Epidemiol 51 (1998) 1285-1292
75. Foley K.M. Pain syndromes in patients with cancer. Med Clin North Am 71 (1987) 169-184
76. Robb K.A., Williams J.E., Duvivier V., et al. A pain management program for chronic cancer-treatment-related pain: a preliminary study. J Pain 7 (2006) 82-90
77. Watkins T., and Maxeiner A. Musculoskeletal effects of ovarian cancer and treatment: a physical therapy perspective. Rehabil Oncol 21 2 (2003) 12-17
78. Servaes P., Verhagen C., and Bleijenberg G. Fatigue in cancer patients and after treatment: prevalence, correlates and interventions. Eur J Cancer 38 (2002) 27-43
79. Broeckel J.A., Jacobsen P.B., Horton J., et al. Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer. J Clin Oncol 16 (1998) 1689-1696
80. Loge J., Abrahamsen A., Ekeberg C., et al. Fatigue and psychiatric morbidity among Hodgkin's disease survivors. J Pain Symptom Manage 19 (2000) 91-99
81. Servaes P., van-der-Werf S., Prins J., et al. Fatigue in disease-free cancer patients compared with fatigue in patients with chronic fatigue syndrome. Support Care Cancer 9 (2001) 11-17
82. Longman A.J., Braden C.J., and Mishel M.H. Side effects burden, psychological adjustment, and life quality in women with breast cancer: pattern of association over time. Oncol Nurs Forum 26 (1999) 909-915
83. Mallinson T., Cella D., Cashy J., et al. Giving meaning to measure: linking self-reported fatigue and function to performance of everyday activities. J Pain Symptom Manage 31 (2006) 229-241
84. Van Weert E., Hoekstra-Weebers J., Otter R., et al. Cancer-related fatigue: predictors and effects of rehabilitation. Oncologist 11 (2006) 184-196
85. Matsuda T., Takamaya T., Tashiro M., et al. Mild cognitive impairment after adjuvant chemotherapy in breast cancer patients-evaluation of appropriate research design and methodology to measure symptoms. Breast Cancer 12 (2005) 279-287
86. Bender C.M., Ergun F.S., Rosensweig M.Q., et al. Symptom clusters in breast cancer across 3 phases of the disease. Cancer Nurs 28 (2005) 219-225
87. Hickey M., Saunders C.M., and Stuckey B.G.A. Management of menopausal symptoms in patients with breast cancer: an evidence-based approach. Lancet Oncol 6 (2005) 687-695
88. Mock V., Frangakis C., Davidson N.E., et al. Exercise manages fatigue during breast cancer treatment: a randomized controlled trial. Psychooncology 14 (2005) 464-477
89. Hewitt J.A., Mokbel K., van Someren K.A., et al. Exercise for breast cancer survival: the effect on cancer risk and cancer-related fatigue. Int J Fertil 50 (2005) 231-239
90. Carroll D.G. Nonhormonal therapies for hot flashes in menopause. Am Fam Physician 73 (2006) 457-464 467
91. Perez D.G., and Loprinzi C.L. Newer antidepressants and other nonhormonal agents for the treatment of hot flashes. Compr Ther 31 (2005) 224-236
92. Stearns V., and Loprinzi C.L. New therapeutic approaches for hot flashes in women. J Support Oncol 1 (2003) 11-21
93. Pandya K.J., Morrow G.R., Roscoe J.A., et al. Lancet 366 (2005) 818-824